Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.4B bought by 663 insiders at 399 companies
- $17B sold by 993 insiders outside a trading plan
- $9.9B sold by 1231 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
COE51Talk Online Education GroupJack Jiajia HuangCEO$102M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
BIRKBirkenstock Holding plcJames Michael ChuDirector$1.1B
-
NVDANvidia Corporation ComMark A StevensDirector$947M
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
JMKEJersey Mike's Subs Inc.Blackstone Holdings II L.P.10% owner · +4 joint filers$705M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$654M
-
ALHAlliance Laundry Holdings Inc.Bdt Capital Partners, LLCDirector · +6 joint filers$590M
-
CRBGCorebridge Financial Inc.Argon Holdco LLC10% owner · +5 joint filers$491M
-
CRWVCoreWeave, Inc.Magnetar Financial LLC10% owner · +3 joint filers$479M
-
ANETArista Networks, Inc.Jayshree UllalCEO$446M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Harvey L Sonnenberg DirectorDBIDesigner Brands Inc.Sale$148K 24,000 shares at $6.15 46% of stakeTraded Sep 17 Filed Sep 21
-
Stephen J Barnard ChairAVOMission Produce, Inc.Sale$446K 35,562 shares at $12.55 2% of stakeTraded Sep 18 Filed Sep 21
-
Benjamin Hohl CFOELVNEnliven Therapeutics, Inc.Planned sale$303K 6,018 shares at $50.35 14% of stakeTraded Sep 17 Filed Sep 21
-
James F Lynch DirectorGSATGlobalstar, Inc.Sale$29.8M 361,600 shares at $82.52 51% of stakeTraded Sep 18 Filed Sep 21
-
Helen Louise Collins Chief Medical OfficerELVNEnliven Therapeutics, Inc.Planned sale$252K 5,000 shares at $50.35 17% of stakeTraded Sep 17 Filed Sep 21
-
Marc Boroditsky Chief Revenue OfficerNBISNebius Group N.V.Planned sale$5.5M 26,886 shares at $205.87 100% of stakeTraded Jun 15–Jul 15 Filed Sep 21
-
Benjamin Louis Kirchhoff Chief Accounting OfficerIOTSamsara Inc.Planned sale$31K 770 shares at $40.42 0.5% of stakeTraded Sep 18 Filed Sep 21
-
Kecia Steelman CEOULTAUlta Beauty, Inc.Sale$1.1M 2,000 shares at $545.88 4.7% of stakeTraded Sep 17 Filed Sep 21
-
Karen Akinsanya See RemarksSDGRSchrodinger, Inc.Planned sale$928K 31,599 shares at $29.37 31% of stakeTraded Sep 17 Filed Sep 21
-
Gary Mark Bendza CFOTLSTelos CorporationSale$707K 174,539 shares at $4.05 34% of stakeTraded Sep 18 Filed Sep 21
-
Diana Sroka DirectorSOUNSoundHound AI, Inc.Planned sale$9,483 1,552 shares at $6.11 0.9% of stakeTraded Sep 17 Filed Sep 21
-
Jonathan W Thayer CFOVGVenture Global, Inc.Planned sale$3.2M 222,222 shares at $14.31 100% of stakeTraded Sep 17–18 Filed Sep 21
-
William Andrew Hendricks Jr. CEOPTENPatterson-UTI Energy, Inc.Planned sale$3M 250,000 shares at $11.91 11% of stakeTraded Sep 18 Filed Sep 21
-
Bernd Greifeneder EVP, Chief Technology OfficerDTDynatrace, Inc.Planned sale$2.9M 50,000 shares at $57.21 5.2% of stakeTraded Sep 18 Filed Sep 21
-
Paul T Quinlan General CounselORKAOruka Therapeutics, Inc.Planned sale$936K 10,000 shares at $93.64 25% of stakeTraded Sep 21 Filed Sep 21
-
Thomas J Seifert CFONETCloudflare, Inc.Planned sale$3.3M 10,000 shares at $332.46 8.5% of stakeTraded Sep 17 Filed Sep 21
-
Daniel Waldemar Bradtke DirectorROLRHigh Roller Technologies, Inc.Sale$31K 5,000 shares at $6.16 14% of stakeTraded Sep 17 Filed Sep 21
-
Tricia D Smith CEOURBNUrban Outfitters, Inc.Sale$266K 3,500 shares at $75.95 10% of stakeTraded Sep 18 Filed Sep 21
-
Scott R. Lovett President, Go to MarketFSLYFastly, Inc.Planned sale$1M 41,815 shares at $24.64 3.2% of stakeTraded Sep 17 Filed Sep 21
-
Jeffrey Ford Principal Accounting OfficerFSLYFastly, Inc.Planned sale$1.1M 45,832 shares at $24.65 16% of stakeTraded Sep 17 Filed Sep 21
-
Artur Bergman Chief Technology OfficerFSLYFastly, Inc.Planned sale$56K 2,200 shares at $25.30 0.1% of stakeTraded Sep 17 Filed Sep 21
-
Peng Jonathan Zhao CEOBZKanzhun LimitedSale$110M 15.2M shares at $7.25Traded Sep 21 Filed Sep 21
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $494.79 2.8% of stakeTraded Sep 18 Filed Sep 21
-
Silver Lake Technology Investors V, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$274K 468 shares at $585.90 100% of stakeTraded Sep 17 Filed Sep 21
-
Silver Lake Technology Investors IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$607K 1,036 shares at $585.92 100% of stakeTraded Sep 17 Filed Sep 21
-
Silver Lake Partners IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$30.7M 52,488 shares at $585.77Traded Sep 17 Filed Sep 21
-
Sl Spv-2, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$27.1M 46,253 shares at $585.91 29% of stakeTraded Sep 17 Filed Sep 21
-
Silver Lake Partners V DE (AIV), L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$15.6M 26,553 shares at $585.91 31% of stakeTraded Sep 17 Filed Sep 21
-
David Fisher ChairENVAEnova International, Inc.Planned sale$3.7M 20,750 shares at $178.24 6.3% of stakeTraded Sep 17 Filed Sep 21
-
Hope F Cochran DirectorMDBMongoDB, Inc.Planned sale$376K 1,000 shares at $375.92 3.4% of stakeTraded Sep 17 Filed Sep 21
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$6.7M 10,880 shares at $620.40 2.1% of stakeTraded Sep 17 Filed Sep 21
-
Chi Fung Cheng Chief Technology OfficerCRDOCredo Technology Group Holding LtdPlanned sale$4.6M 27,500 shares at $166.38 0.5% of stakeTraded Sep 17 Filed Sep 21
-
Peng Lu PresidentPHVSPharvaris N.V.Sale$3.5M 100,000 shares at $35.00 61% of stakeTraded Sep 17 Filed Sep 21
-
James J Goetz DirectorPANWPalo Alto Networks, Inc.Sale$7.5M 20,000 shares at $376.68 100% of stakeTraded Sep 17 Filed Sep 21
-
Johannes Gerardus Christiaan Petrus Schikan DirectorPHVSPharvaris N.V.Sale$7M 200,000 shares at $35.00 64% of stakeTraded Sep 17 Filed Sep 21
-
Andy Dignan PresidentFIVNFive9, Inc.Planned sale$245K 6,986 shares at $35.00 2.9% of stakeTraded Sep 17 Filed Sep 21
-
David Alan Kennedy CFODELLDell Technologies Inc.Sale$14M 23,896 shares at $585.02 13% of stakeTraded Sep 17 Filed Sep 21
-
Richard J Rothberg General Counsel & SecretaryDELLDell Technologies Inc.Sale$2.3M 4,000 shares at $583.36 2.9% of stakeTraded Sep 17 Filed Sep 21
-
Bertram L Scott DirectorEQHEquitable Holdings, Inc.Sale$151K 2,780 shares at $54.35 11% of stakeTraded Sep 21 Filed Sep 21
-
David L. Liniger 10% ownerREAXReal REMAX Group Inc.Sale$1M 52,876 shares at $19.12 0.9% of stakeTraded Sep 17 Filed Sep 21
-
Emily M. Leproust CEOTWSTTwist Bioscience CorporationPlanned sale$56.3M 356,546 shares at $157.99 37% of stakeTraded Sep 17 Filed Sep 21
-
Keith Yandell Chief Business OfficerDASHDoorDash, Inc.Planned sale$438K 2,184 shares at $200.76 1.8% of stakeTraded Sep 17 Filed Sep 21
-
Phillip Andrew Dennis Chief Medical OfficerNBPNovaBridge BiosciencesSale$5,828 8,209 shares at $0.7100 4.5% of stakeTraded Sep 18 Filed Sep 21
-
Hershey Trust Co. Trustee In Trust For Milton Hershey School 10% ownerHSYHershey Company (The)Planned sale$3.4M 20,000 shares at $169.08 2.5% of stakeTraded Sep 17–18 Filed Sep 21
-
Susan A Johnson DirectorSANMSanmina CorporationPlanned sale$24K 120 shares at $200.46 1.2% of stakeTraded Sep 17 Filed Sep 21
-
Elisabeth Bjork DirectorPHVSPharvaris N.V.Sale$2M 52,500 shares at $37.89 78% of stakeTraded Sep 17 Filed Sep 21
-
Robert Glassman DirectorPHVSPharvaris N.V.Planned sale$559K 14,493 shares at $38.56 58% of stakeTraded Sep 17 Filed Sep 21
-
Anne Lesage Chief Early DevelopmentPHVSPharvaris N.V.Sale$765K 20,000 shares at $38.27 21% of stakeTraded Sep 17 Filed Sep 21
-
Andrew C Sagliocca CEOESQEsquire Financial Holdings, Inc.Sale$1.2M 10,000 shares at $122.73 3.3% of stakeTraded Sep 18 Filed Sep 21
-
Mary Ellen Adcock Executive Vice PresidentKRKroger CompanySale$4.4M 72,901 shares at $60.70 29% of stakeTraded Sep 18 Filed Sep 21
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.